$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000088559015000015 Filed on February 25, 2015

Income Statement

Concept	2013 Q4	2012 Q4	2012
Revenue	$2.064B	$920.1M	$3.480B
YoY Change	124.3%	33.64%	43.38%
Cost Of Revenue	$731.9M	$217.8M	$905.1M
YoY Change	236.04%	17.98%	32.37%
Gross Profit	$1.332B	$702.2M	$2.575B
YoY Change	89.68%	39.38%	47.69%
Gross Profit Margin	64.54%	76.32%	73.99%
Selling, General & Admin	$450.3M	$204.7M	$756.1M
YoY Change	119.98%	37.85%	32.08%
% of Gross Profit	33.81%	29.15%	29.36%
Research & Development	$59.50M	$20.20M	$79.10M
YoY Change	194.55%	20.24%	20.42%
% of Gross Profit	4.47%	2.88%	3.07%
Depreciation & Amortization	$410.5M	$313.4M	$54.80M
YoY Change	30.98%	50.38%	20.18%
% of Gross Profit	30.82%	44.63%	2.13%
Operating Expenses	$297.7M	$604.3M	$835.2M
YoY Change	-50.74%	68.75%	30.88%
Operating Profit	$1.034B	$97.90M	$79.70M
YoY Change	956.38%	-32.81%	-73.43%
Interest Expense	-$266.2M	-$158.9M	-$454.0M
YoY Change	67.53%	135.06%	61.57%
% of Operating Profit	-25.74%	-162.31%	-569.64%
Other Income/Expense, Net			$59.35M
YoY Change			802.65%
Pretax Income	-$78.10M	-$274.6M	-$205.6M
YoY Change	-71.56%	258.02%	396.93%
Income Tax	-$203.1M	-$185.5M	-$278.2M
% Of Pretax Income
Net Earnings	$123.8M	-$89.10M	-$116.0M
YoY Change	-238.95%	-259.39%	-172.7%
Net Earnings / Revenue	6.0%	-9.68%	-3.33%
Basic Earnings Per Share			-$0.38
Diluted Earnings Per Share	$370.1K	-$292.1K	-$0.38
COMMON SHARES
Basic Shares Outstanding	333.9M shares	304.8M shares	305.4M shares
Diluted Shares Outstanding			305.4M shares

Balance Sheet

Concept	2013 Q4	2012 Q4	2012
SHORT-TERM ASSETS
Cash & Short-Term Investments	$600.0M	$920.5M	$916.0M
YoY Change	-34.82%	440.08%	438.82%
Cash & Equivalents	$600.0M	$916.1M	$916.0M
Short-Term Investments		$4.410M
Other Short-Term Assets	$726.0M	$416.0M	$416.0M
YoY Change	74.52%	58.17%	58.17%
Inventory	$883.0M	$531.3M	$531.0M
Prepaid Expenses
Receivables	$1.676B	$769.5M	$769.0M
Other Receivables	$0.00	$0.00	$145.0M
Total Short-Term Assets	$3.886B	$2.777B	$2.777B
YoY Change	39.91%	104.6%	104.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.234B	$462.7M	$463.0M
YoY Change	166.72%	11.7%	11.84%
Goodwill	$9.752B	$5.141B
YoY Change	89.68%	43.55%
Intangibles	$12.85B	$9.309B
YoY Change	38.02%	21.82%
Long-Term Investments
YoY Change
Other Assets	$195.5M	$183.7M	$260.0M
YoY Change	6.4%	213.03%	130.09%
Total Long-Term Assets	$24.05B	$15.17B	$15.17B
YoY Change	58.49%	29.12%	29.13%
TOTAL ASSETS
Total Short-Term Assets	$3.886B	$2.777B	$2.777B
Total Long-Term Assets	$24.05B	$15.17B	$15.17B
Total Assets	$27.93B	$17.95B	$17.95B
YoY Change	55.61%	36.94%	36.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$327.0M	$227.4M	$227.0M
YoY Change	43.81%	44.26%	43.67%
Accrued Expenses	$1.800B	$1.008B	$971.0M
YoY Change	78.55%	91.1%	83.9%
Deferred Revenue
YoY Change
Short-Term Debt	$12.10M	$10.55M	$11.00M
YoY Change	14.71%
Long-Term Debt Due	$204.8M	$480.2M	$480.0M
YoY Change	-57.35%	331.62%	332.43%
Total Short-Term Liabilities	$2.513B	$1.823B	$1.823B
YoY Change	37.84%	97.21%	97.29%
LONG-TERM LIABILITIES
Long-Term Debt	$17.16B	$10.54B	$10.54B
YoY Change	62.91%	61.1%	61.09%
Other Long-Term Liabilities	$160.5M	$165.0M	$626.0M
YoY Change	-2.71%	115.14%	19.01%
Total Long-Term Liabilities	$17.32B	$10.70B	$11.16B
YoY Change	61.89%	61.72%	57.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.513B	$1.823B	$1.823B
Total Long-Term Liabilities	$17.32B	$10.70B	$11.16B
Total Liabilities	$22.74B	$14.23B	$14.23B
YoY Change	59.75%	55.07%	55.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.279B	-$2.371B
YoY Change	38.28%	16.78%
Common Stock	$8.530B	$6.208B
YoY Change	37.41%	-0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.119B	$3.717B	$3.717B
YoY Change
Total Liabilities & Shareholders Equity	$27.97B	$17.95B	$17.95B
YoY Change	55.82%	36.94%	36.94%

Cashflow Statement

Concept	2013 Q4	2012 Q4	2012
OPERATING ACTIVITIES
Net Income	$123.8M	-$89.10M	-$116.0M
YoY Change	-238.95%	-259.39%	-172.7%
Depreciation, Depletion And Amortization	$410.5M	$313.4M	$54.80M
YoY Change	30.98%	50.38%	20.18%
Cash From Operating Activities	$279.9M	$67.90M	$656.6M
YoY Change	312.22%	-64.23%	2.51%
INVESTING ACTIVITIES
Capital Expenditures	-$95.10M	-$90.40M	$107.6M
YoY Change	5.2%	368.39%	83.88%
Acquisitions			$3.485B
YoY Change			41.44%
Other Investing Activities	-$49.50M	-$1.883B	-$2.785B
YoY Change	-97.37%	25.99%	14.94%
Cash From Investing Activities	-$144.6M	-$1.974B	-$2.966B
YoY Change	-92.67%	30.37%	5.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$280.7M
YoY Change			-56.09%
Debt Paid & Issued, Net			$1.929B
YoY Change			-3.77%
Cash From Financing Activities	-130.9M	2.562B	$3.057B
YoY Change	-105.11%	107.21%	56.93%
NET CHANGE
Cash From Operating Activities	279.9M	67.90M	$656.6M
Cash From Investing Activities	-144.6M	-1.974B	-$2.966B
Cash From Financing Activities	-130.9M	2.562B	$3.057B
Net Change In Cash	4.400M	656.4M	$748.2M
YoY Change	-99.33%	-849.32%	-440.4%
FREE CASH FLOW
Cash From Operating Activities	$279.9M	$67.90M	$656.6M
Capital Expenditures	-$95.10M	-$90.40M	$107.6M
Free Cash Flow	$375.0M	$158.3M	$549.0M
YoY Change	136.89%	-24.29%	-5.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	336202718	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	37219586000	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	Valeant Pharmaceuticals International, Inc.
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	327000000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	398000000	USD
CY2013Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1704000000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2111700000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1676400000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2075800000	USD
CY2013Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	19300000	USD
CY2014Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	33300000	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	201200000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	204900000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	39100000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	122900000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1800200000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2179400000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	46300000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	55600000	USD
CY2013Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	37600000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	41400000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	838800000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	977900000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-279600000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-119400000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132800000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-915900000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	228800000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	243900000	USD
CY2012	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-31100000	USD
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-46600000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-44100000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	66200000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45500000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78200000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	12500000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	24200000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	17100000	USD
CY2012	us-gaap	Advertising Expense AdvertisingExpense	157600000	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	277300000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	435400000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	66200000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45500000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40300000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27600000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35900000	USD
CY2012	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	36400000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	89500000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	70000000	USD
CY2012Q4	us-gaap	Assets Assets	17950400000	USD
CY2013Q4	us-gaap	Assets Assets	27970800000	USD
CY2014Q4	us-gaap	Assets Assets	26353000000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	3885900000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	4193100000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	15900000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	8900000	USD
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-2.14
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-2.43
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	2.71
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-2.14
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-2.43
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	2.66
CY2012	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-709600000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-801900000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	909300000	USD
CY2012	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7700600000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7929900000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	8348900000	USD
CY2012	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	78600000	USD
CY2013	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36400000	USD
CY2014	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6300000	USD
CY2012	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	5300000	USD
CY2013	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	29200000	USD
CY2014	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	14100000	USD
CY2013Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	114500000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	141800000	USD
CY2014	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed	122000000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164100000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916100000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600300000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322600000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2014Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	333036637	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334402964	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	333036637	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334402964	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	8301200000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8349200000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	44200000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-879500000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	130400000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2800000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2900000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	44200000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-876700000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	127500000	USD
CY2014Q4	us-gaap	Contractual Obligation ContractualObligation	70000000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	905100000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1846300000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2196200000	USD
CY2012	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	64600000	USD
CY2013	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	58800000	USD
CY2014	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	58400000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	3400700000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	6179100000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	6223800000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7200000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3400000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	600000	USD
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	56300000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	80000000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	150100000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	63500000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	83400000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	150700000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	15391000000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	136400000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11900000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-329800000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-534200000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	29700000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-341700000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-534200000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	29700000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	12500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1978500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2025500000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-1963400000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-1990900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	366900000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	193300000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1500900000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1166300000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	54900000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	54000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	76500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	38200000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	126400000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	234900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	43000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	49800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	577500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	369900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	477600000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	859200000	USD
CY2012	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	-12500000	USD
CY2013	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	-24200000	USD
CY2014	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	-17100000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3464300000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3157200000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	66000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	10700000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2884300000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	520000000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2319200000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2227500000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	19500000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	18800000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	563800000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2636600000	USD
CY2014	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1	900000	USD
CY2014	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	1000000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2800000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	16400000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	20500000	USD
CY2012	us-gaap	Depreciation Depreciation	54800000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-144100000	USD
CY2013	us-gaap	Depreciation Depreciation	113800000	USD
CY2014	us-gaap	Depreciation Depreciation	186900000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	986200000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2015800000	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1737600000	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.70
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.72
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.70
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.67
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	3800000	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-5200000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-29000000	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2014	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	397500000	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	12500000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	24200000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	17100000	USD
CY2014Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	29200000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	14100000	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	5000000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	4100000	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	141200000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	116800000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	455100000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	355800000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	308800000	USD
CY2014	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3827400000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5140600000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1376100000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	949800000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1093600000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1216300000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1280100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14398800000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14408900000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10571400000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9268300000	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	19700000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9400000	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	23800000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-9800000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-135100000	USD
CY2012	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-106000000	USD
CY2013	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-353600000	USD
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	293900000	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-10800000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-10200000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	253500000	USD
CY2012	us-gaap	Gain Loss On Investments GainLossOnInvestments	2100000	USD
CY2013	us-gaap	Gain Loss On Investments GainLossOnInvestments	5800000	USD
CY2014	us-gaap	Gain Loss On Investments GainLossOnInvestments	292600000	USD
CY2012	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-56800000	USD
CY2013	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-220500000	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	44700000	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20100000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-65000000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-93700000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-129600000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	5141400000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	9752100000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	9346400000	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4595200000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	396300000	USD
CY2013	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	28100000	USD
CY2014	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-23900000	USD
CY2013	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-12600000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-349200000	USD
CY2014	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	428900000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-205600000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-574500000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-851100000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-188600000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-739900000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1943700000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-394200000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1314400000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1092600000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-278200000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-450800000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180400000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-34200000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	143900000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	255200000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-4500000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	6600000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	29700000	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-226800000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-407600000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-502800000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	6200000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	0	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	0	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	3200000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	0	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	0	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	6300000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	13100000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	19800000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3800000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	21800000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-29100000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	3100000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	50100000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	41400000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	65100000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	98700000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8400000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-76500000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	188600000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	175800000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	300600000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	572400000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	80300000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	122700000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	174300000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11200000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-121500000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	110300000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	8900000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6100000	shares
CY2013Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16675600000	USD
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16396500000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12848200000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11255900000	USD
CY2012	us-gaap	Interest And Debt Expense InterestAndDebtExpense	481600000	USD
CY2013	us-gaap	Interest And Debt Expense InterestAndDebtExpense	844300000	USD
CY2014	us-gaap	Interest And Debt Expense InterestAndDebtExpense	971000000	USD
CY2012	us-gaap	Interest Paid InterestPaid	421000000	USD
CY2013	us-gaap	Interest Paid InterestPaid	652900000	USD
CY2014	us-gaap	Interest Paid InterestPaid	934000000	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	231300000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	196700000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	656300000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	732700000	USD
CY2013Q4	us-gaap	Inventory Gross InventoryGross	982800000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	1063500000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	883000000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	950600000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	221800000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	232800000	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	99800000	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	112900000	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	104700000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	98000000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	22737500000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	20918500000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27970800000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26353000000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2512500000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2730800000	USD
CY2013Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	8700000	USD
CY2014Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	6800000	USD
CY2013Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	169100000	USD
CY2014Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	102600000	USD
CY2013Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	55900000	USD
CY2014Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	8000000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	17367700000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	15254600000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	204800000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	900000	USD
CY2013Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	18400000000	USD
CY2014Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	15800000000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	9224700000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	900000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1961400000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3204500000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	360200000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	639300000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	122300000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	114600000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17162900000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15253700000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2100000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2200000	USD
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3300000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	752000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-315800000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-277700000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3057300000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4027700000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2443700000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2965700000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5380300000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99700000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	656600000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1042000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2294700000	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2500000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1300000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-116000000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-866100000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	913500000	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	825200000	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4264700000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	11200000	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	113900000	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	15000000	USD
CY2012Q4	us-gaap	Noncurrent Assets NoncurrentAssets	462700000	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1234200000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1310500000	USD
CY2014Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
CY2014	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2014	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	79700000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-409500000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	2039700000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	195700000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	44200000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	15700000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	18000000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	28800000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	35700000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	53300000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	22900000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	51900000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	75000000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	172000000	USD
CY2012	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	41800000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	210700000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	195500000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	193100000	USD
CY2012	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-27900000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-29400000	USD
CY2012	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-200000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-37800000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	66900000	USD
CY2012	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-500000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	24500000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-127300000	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	161000000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-50500000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-717800000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-2500000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	160000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-50900000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-717800000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	161000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50800000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-716200000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-200000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-5200000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	160200000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13100000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-784700000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-200000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-37800000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	66900000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1400000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	4000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1800000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	15400000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-27400000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	160500000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	197100000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	13600000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3800000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-32300000	USD
CY2012	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-136600000	USD
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-287200000	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	268700000	USD
CY2013	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	180800000	USD
CY2014	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	3200000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	280700000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55600000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2012	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	33200000	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	116300000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	55200000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30700000	USD
CY2012	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	31100000	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	65500000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	44100000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3485300000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5253500000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1102600000	USD
CY2012	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	75900000	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	73500000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	69600000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	179000000	USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7200000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18200000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	72000000	USD
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	107600000	USD
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	115300000	USD
CY2014	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	291600000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107600000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115300000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	291600000	USD
CY2012	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4000000	USD
CY2013	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2100000	USD
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	8200000	USD
CY2013Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	172000000	USD
CY2014Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	239800000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	343400000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	641900000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2307400000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	6005800000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8429600000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1632600000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	624800000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	35200000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	53200000	USD
CY2012	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	75900000	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	92000000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41100000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1492300000	USD
CY2012	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	35400000	USD
CY2013	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	27400000	USD
CY2014	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	19400000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23000000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17200000	USD
CY2012	us-gaap	Profit Loss ProfitLoss	-116000000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-863600000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	912200000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2073000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2288400000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1234200000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1310500000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1676400000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2075800000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1929100000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6326200000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3888000000	USD
CY2012	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	31100000	USD
CY2013	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	75100000	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	28400000	USD
CY2012	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	79100000	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	156800000	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	246000000	USD
CY2012	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	167700000	USD
CY2013	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	151900000	USD
CY2014	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	21000000	USD
CY2012	us-gaap	Restructuring Charges RestructuringCharges	267100000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	462000000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	381700000	USD
CY2013Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	112000000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	66600000	USD
CY2013	us-gaap	Restructuring Reserve Settled Without Cash1 RestructuringReserveSettledWithoutCash1	0	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3278500000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2365000000	USD
CY2012	us-gaap	Revenues Revenues	3480400000	USD
CY2013	us-gaap	Revenues Revenues	5769600000	USD
CY2014	us-gaap	Revenues Revenues	8263500000	USD
CY2012	us-gaap	Royalty Revenue RoyaltyRevenue	191800000	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	129300000	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	159900000	USD
CY2013Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	25900000	USD
CY2014Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	24700000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3288600000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5640300000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8103600000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	756100000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1305200000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2026300000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	66200000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	45500000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	78200000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	12100000	USD
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6200000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	27058824	shares
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	43800000	USD
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2300000000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2306900000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23200000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6400000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16100000	USD
CY2012	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	280700000	USD
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55600000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	3929800000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	3717400000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	5118700000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	5312200000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5233300000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5434500000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	102300000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	128000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	247500000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	345000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1400000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	10800000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	50200000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	46400000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	38700000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	5700000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7700000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3500000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	60700000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	143000000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19400000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	12800000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	8100000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	153400000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	108700000	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	353100000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	381600000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	305400000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	321000000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341500000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305400000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	321000000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335400000	shares
CY2013Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	27200000	USD
CY2014Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	25600000	USD
CY2013Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	566600000	USD
CY2014Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	714900000	USD
CY2013Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	225500000	USD
CY2014Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	380300000	USD
CY2014Q4	vrx	Accumulated Losses Preacquisition Non Qualified Stock Options And Restricted Stock Awards AccumulatedLossesPreacquisitionNonQualifiedStockOptionsAndRestrictedStockAwards	95500000	USD
CY2012	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	78800000	USD
CY2013	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	372400000	USD
CY2014	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	27300000	USD
CY2012	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	21800000	USD
CY2013	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	68300000	USD
CY2014	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	81300000	USD
CY2012	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	928900000	USD
CY2013	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1902000000	USD
CY2014	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1550700000	USD
CY2012	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	145700000	USD
CY2013	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	76100000	USD
CY2014	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	93800000	USD
CY2012	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	58100000	USD
CY2013	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	369900000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	20200000	USD
CY2012	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	72100000	USD
CY2013	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	25300000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	2000000	USD
CY2012	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-5300000	USD
CY2013	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-29200000	USD
CY2014	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-14100000	USD
CY2014	vrx	Business Combination Contingent Consideration Arrangements Fair Value Adjustment BusinessCombinationContingentConsiderationArrangementsFairValueAdjustment	19000000	USD
CY2013Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	241300000	USD
CY2014Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	167000000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payment Period CollaborativeAgreementMilestonePaymentPeriod	P5Y
CY2014Q4	vrx	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	1000000000	USD
CY2013Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	0	USD
CY2014Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	62000000	USD
CY2013Q4	vrx	Collaborative Agreement Milestone Payments Due Potential CollaborativeAgreementMilestonePaymentsDuePotential	80000000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payments Due Potential CollaborativeAgreementMilestonePaymentsDuePotential	150000000	USD
CY2014	vrx	Concentration Risk Percentageof Net Trade Receivables ConcentrationRiskPercentageofNetTradeReceivables	0.33
CY2014	vrx	Debt Instrument Redemption Price As Percentage Of Principal Amount DebtInstrumentRedemptionPriceAsPercentageOfPrincipalAmount	1.01
CY2013Q2	vrx	Deferred Compensation Arrangementwith Individual Compensation Expense Increase Decrease Reclassificationof Award DeferredCompensationArrangementwithIndividualCompensationExpenseIncreaseDecreaseReclassificationofAward	21300000	USD
CY2012	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-319600000	USD
CY2013	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-515900000	USD
CY2014	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	81800000	USD
CY2013Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	0	USD
CY2014Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	209400000	USD
CY2013Q4	vrx	Deferred Tax Assets Plant Equipment And Technology DeferredTaxAssetsPlantEquipmentAndTechnology	38300000	USD
CY2014Q4	vrx	Deferred Tax Assets Plant Equipment And Technology DeferredTaxAssetsPlantEquipmentAndTechnology	2800000	USD
CY2013Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	62900000	USD
CY2014Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	58200000	USD
CY2013Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	83700000	USD
CY2014Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	90500000	USD
CY2013Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	957700000	USD
CY2014Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	958300000	USD
CY2013Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	16600000	USD
CY2014Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	0	USD
CY2013Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	-400000	USD
CY2014Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	600000	USD
CY2014	vrx	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.1
CY2014	vrx	Defined Benefit Plan Employer Contribution Maximum Age DefinedBenefitPlanEmployerContributionMaximumAge	P65Y
CY2014	vrx	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2014Q4	vrx	Estimated Unrecognized Tax Benefits Realized In Next Twelve Months EstimatedUnrecognizedTaxBenefitsRealizedInNextTwelveMonths	4700000	USD
CY2013	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	0	USD
CY2014	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	5800000	USD
CY2012	vrx	Income Tax Reconciliation Alternative Minimum And Other Taxes IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes	-4500000	USD
CY2013	vrx	Income Tax Reconciliation Alternative Minimum And Other Taxes IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes	0	USD
CY2014	vrx	Income Tax Reconciliation Alternative Minimum And Other Taxes IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes	0	USD
CY2012	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	0	USD
CY2013	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	70200000	USD
CY2014	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	17400000	USD
CY2012	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-10400000	USD
CY2013	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-5700000	USD
CY2014	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-147300000	USD
CY2012	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	9100000	USD
CY2013	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	600000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	22800000	USD
CY2012	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	8000000	USD
CY2013	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	3400000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	3700000	USD
CY2012	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	24200000	USD
CY2013	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	1100000	USD
CY2014	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	0	USD
CY2012	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	10700000	USD
CY2013	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	55400000	USD
CY2014	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	269000000	USD
CY2012	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	15400000	USD
CY2013	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	0	USD
CY2014	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-1800000	USD
CY2012	vrx	Income Tax Reconciliation Unrecognized Tax Benefits IncomeTaxReconciliationUnrecognizedTaxBenefits	32000000	USD
CY2013	vrx	Income Tax Reconciliation Unrecognized Tax Benefits IncomeTaxReconciliationUnrecognizedTaxBenefits	0	USD
CY2014	vrx	Income Tax Reconciliation Unrecognized Tax Benefits IncomeTaxReconciliationUnrecognizedTaxBenefits	0	USD
CY2014	vrx	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2014	vrx	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2012	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-700000	USD
CY2013	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-600000	USD
CY2014	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-900000	USD
CY2012	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2013	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	51300000	USD
CY2012	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	-200000	USD
CY2013	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	0	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax	0	USD
CY2012	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	1600000	USD
CY2013	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	4000000	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	1800000	USD
CY2012	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	51300000	USD
CY2012	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	400000	USD
CY2013	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	3600000	USD
CY2014	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	1800000	USD
CY2013	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2014	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2012	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	2300000	USD
CY2013	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	11100000	USD
CY2014	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	10700000	USD
CY2012	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	103900000	USD
CY2013	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	130100000	USD
CY2014	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	106100000	USD
CY2014	vrx	Period Receivable Outstanding PeriodReceivableOutstanding	P90D
CY2012	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	313100000	shares
CY2013	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	327500000	shares
CY2012	vrx	Repurchase Of Equity Component Of Convertible Debt RepurchaseOfEquityComponentOfConvertibleDebt	2900000	USD
CY2012	vrx	Researchand Development In Process And Other Charges ResearchandDevelopmentInProcessAndOtherCharges	189900000	USD
CY2013	vrx	Researchand Development In Process And Other Charges ResearchandDevelopmentInProcessAndOtherCharges	153600000	USD
CY2014	vrx	Researchand Development In Process And Other Charges ResearchandDevelopmentInProcessAndOtherCharges	41000000	USD
CY2013Q2	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	85.00
CY2012	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	606300000	USD
CY2013	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	0	USD
CY2014	vrx	Settlement Of Convertible Debt SettlementOfConvertibleDebt	0	USD
CY2013Q2	vrx	Sharebased Compensation Expense Increase Decrease Reclassificationof Award SharebasedCompensationExpenseIncreaseDecreaseReclassificationofAward	-5800000	USD
CY2014Q3	vrx	Significant Acquisitions And Disposals Period Of Minimum Royalty Payments From Commercialization Of Product SignificantAcquisitionsAndDisposalsPeriodOfMinimumRoyaltyPaymentsFromCommercializationOfProduct	P3Y
CY2014	vrx	Stock Issued During Period Value Equity Settlement And Reclassification Of Call Options StockIssuedDuringPeriodValueEquitySettlementAndReclassificationOfCallOptions	-3100000	USD
CY2012Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	3673200000	USD
CY2013Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	6110000000	USD
CY2014Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	5307000000	USD
CY2014	vrx	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.5
CY2013	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	12800000	USD
CY2014	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	45500000	USD
CY2013Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	247500000	USD
CY2014Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	345000000	USD
CY2013	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	132400000	USD
CY2014	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	143000000	USD
CY2014Q4	vrx	Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate	236300000	USD
CY2014	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation. Such amounts include a reclassification of (i) </font><font style="font-family:inherit;font-size:10pt;">$52.8 million</font><font style="font-family:inherit;font-size:10pt;"> recognized in the third quarter of 2013 related to B&L’s previously cancelled performance-based options and the acceleration of unvested stock options for B&L employees from Restructuring, integration and other costs to Other (income) expense on the consolidated statement of income (loss) and (ii) </font><font style="font-family:inherit;font-size:10pt;">$77.3 million</font><font style="font-family:inherit;font-size:10pt;"> recognized in the fourth quarter of 2012 related to the acceleration of unvested stock options, restricted stock awards, and share appreciation rights for Medicis Pharmaceutical Corporation (“Medicis”) employees that was triggered by the change in control from Restructuring, integration and other costs to Other (income) expense on the consolidated statement of income (loss).</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reclassifications described above had no effect on the Company’s previously reported results of operations, financial position or cash flows.</font></div></div>
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company maintains its cash and cash equivalents with major financial institutions. The Company has not experienced any significant losses on its cash or cash equivalents.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s accounts receivable primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic areas. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Italy, Portugal, Spain and Greece, among other members of the European Union, have remained weak in recent years. These conditions have increased, and may continue to increase, the average length of time that it takes to collect on the Company’s accounts receivable outstanding in these countries. An allowance for doubtful accounts is maintained for potential credit losses based on the aging of accounts receivable, historical bad debts experience, and changes in customer payment patterns. Accounts receivables balances are written off against the allowance when it is probable that the receivable will not be collected.</font></div></div>
CY2014	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the “Company”) is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2013, the Company acquired Bausch & Lomb Holdings Incorporated (“B&L”), pursuant to an Agreement and Plan of Merger, as amended (the “Merger Agreement”) dated May 24, 2013, with B&L surviving as a wholly-owned subsidiary of Valeant Pharmaceuticals International (“Valeant”), a wholly-owned subsidiary of the Company (the “B&L Acquisition”). B&L is a global eye health company that focuses primarily on the development, manufacture and marketing of eye health products, including contact lenses, contact lens care solutions, ophthalmic pharmaceuticals and ophthalmic surgical products.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the B&L Acquisition, see note 3 titled “BUSINESS COMBINATIONS”.</font></div></div>
CY2014	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Sales </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product sales revenue is recognized when title has transferred to the customer and the customer has assumed the risks and rewards of ownership, the timing of which is based on the specific contractual terms with each customer. In most instances, transfer of title as well as the risks and rewards of ownership occurs upon delivery of the product to the customer. Amounts received from customers as prepayments for products to be shipped in the future are recorded in deferred revenue. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is recognized net of provisions for estimated discounts, allowances, returns, rebates, chargebacks and distribution fees paid to certain of our wholesale customers. The Company offers discounts for prompt payment and other incentive allowances to customers. Provisions for discounts and allowances are estimated based on contractual sales terms with customers and historical payment experience. The Company allows customers to return product within a specified period of time before and after its expiration date. Provisions for returns are estimated based on historical return levels, taking into account additional available information on competitive products and contract changes. The Company has data sharing agreements with the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> largest wholesalers in the U.S. Where the Company does not have data sharing agreements, it uses third party data to estimate the level of product inventories and product demand at wholesalers and retail pharmacies. The Company reviews its methodology and adequacy of the provision for returns on a quarterly basis, adjusting for changes in assumptions, historical results and business practices, as necessary. The Company is subject to rebates on sales made under governmental and commercial rebate programs, and chargebacks on sales made to government agencies, retail pharmacies and group purchasing organizations. Provisions for rebates and chargebacks are estimated based on historical experience, relevant statutes with respect to governmental pricing programs, and contractual sales terms.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party to manufacturing and supply agreements with a number of commercialization counterparties in the U.S. Under the terms of these agreements, the Company’s supply prices for its products are determined after taking into consideration estimates for future returns, rebates, and chargebacks provided by each counterparty. The Company makes adjustments as needed to state these estimates on a basis consistent with this policy and its methodology for estimating returns, rebates and chargebacks related to its own direct product sales.</font></div></div>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates, chargebacks, discounts and allowances, and distribution fees paid to certain wholesalers; useful lives of amortizable intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment; reporting unit fair values in testing goodwill for impairment; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; and the allocation of the purchase price for acquired assets and businesses, including the fair value of contingent consideration. Under certain product manufacturing and supply agreements, management relies on estimates for future returns, rebates and chargebacks made by the Company’s commercialization counterparties. On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.</font></div></div>

Files In Submission

Name	View Source	Status
0000885590-15-000015-index-headers.html	Edgar Link	pending
0000885590-15-000015-index.html	Edgar Link	pending
0000885590-15-000015.txt	Edgar Link	pending
0000885590-15-000015-xbrl.zip	Edgar Link	pending
d873633dex102.htm	Edgar Link	pending
d873633dex1020.htm	Edgar Link	pending
d873633dex1021.htm	Edgar Link	pending
d873633dex103.htm	Edgar Link	pending
d873633dex1031.htm	Edgar Link	pending
d873633dex104.htm	Edgar Link	pending
d873633dex1041.htm	Edgar Link	pending
d873633dex1042.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
valeant2014form10-k.htm	Edgar Link	pending
vrx-20141231.xml	Edgar Link	completed
vrx-20141231.xsd	Edgar Link	pending
vrx-20141231_cal.xml	Edgar Link	unprocessable
vrx-20141231_def.xml	Edgar Link	unprocessable
vrx-20141231_lab.xml	Edgar Link	unprocessable
vrx-20141231_pre.xml	Edgar Link	unprocessable
vrxperformancegraph.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2013 Q4 Form 10-K Financial Statement

#000088559015000015 Filed on February 25, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2013 Q4 Form 10-K Financial Statement

#000088559015000015 Filed on February 25, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc